BridgeMD
Comparing intraoperative indocyanine green fluorescence imaging with standard clinical assessment for flap perfusion in head and neck reconstruction: A randomised controlled Trial (VISION Trial)
EU CTIS ID: 2025-524710-29-00
What this study is testing
The primary objective is to compare the incidence of partial flap loss requiring surgical intervention within 1 month between patients undergoing intraoperative ICG angiography and those assessed using standard clinical methods.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- To be included in the trial, subjects must meet all of the following criteria: 1) The subject is able to provide informed consent to the trial. 2) The subject is above 18 years of age. 3) The subject will undergo microvascular free flap reconstruction for oncologic or traumatic head and neck defects.
You likely can't join if
- Subjects meeting any of the following criteria will be excluded: 1) The subject is allergic to indocyanine green or iodine 2) The subject has severe hepatic or renal impairment 3) The subject is pregnant
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.